Regulatory Pathway Logic for Faster Medical Product Development
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The complexity of regulatory pathways for medical products poses challenges for companies, especially smaller organizations, leading to delayed development timelines and increased costs, as traditional methods rely heavily on expert knowledge and are not always up-to-date.
Innovation Solution
A system and method utilizing a host server, user authentication, user interface, regulatory logic, and database to analyze user inputs and identify appropriate regulatory pathways for medical products, incorporating decision trees and open-source code for tailored guidance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional expert-based methods are used to identify regulatory pathways, then accuracy of regulatory guidance is improved, but resource intensity and cost increase
Solution Approach 1:
The patent creates a digital copy of expert knowledge by encoding regulatory pathway identification rules into a computer system. The system captures and reproduces the decision-making logic of experienced regulatory affairs professionals through structured algorithms and databases, making expert knowledge accessible without requiring physical expert involvement for each analysis.
Solution Approach 2:
The system enables organizations to perform regulatory pathway identification independently without relying on external experts. By providing self-contained databases of regulatory requirements and automated analysis capabilities, the system allows users to conduct their own regulatory assessments, reducing dependency on expensive external consultation services.
2Reliability
If traditional expert-based methods are used to identify regulatory pathways, then accuracy of regulatory guidance is improved, but development timeline is extended
Solution Approach 1:
The patent replaces the mechanical process of human expert consultation with an automated computer-based system. Instead of scheduling meetings, reviewing documents, and iterating through expert feedback loops, the system provides instant automated analysis through software algorithms, dramatically reducing the time required to identify appropriate regulatory pathways while maintaining accuracy through structured decision logic.
3Reliability
If comprehensive regulatory analysis is performed manually, then completeness of regulatory strategy is improved, but productivity decreases
Solution Approach 1:
The patent breaks down the complex regulatory analysis process into discrete, manageable segments including product type classification, indication analysis, population characteristics, and pathway determination. Each segment is handled by specific software modules that systematically evaluate different aspects of the regulatory landscape, ensuring comprehensive coverage while enabling parallel processing and faster overall analysis.
Solution Approach 2:
The system is designed as a universal platform capable of analyzing diverse medical products across multiple therapeutic areas and regulatory jurisdictions simultaneously. By creating a multi-functional system that can handle drugs, devices, biologics, and combination products through a unified interface, the patent achieves both comprehensive regulatory analysis and high productivity through standardized automated processes.
Data Source
AI summary
An identification system for identifying regulatory pathways for medical product development including a host server, a user authentication system, a user interface, regulatory logic for identifying a regulatory affairs development pathway, and a regulatory database. The regulatory logic analyzes user responses to determine regulatory pathways based on information stored in the regulatory database. The user authentication system stores account preferences, payment methods, identified regulatory pathways, and/or product development information. The regulatory logic communicates with the user interface to present prompts, questions, input fields, and/or guiding comments to the user. The regulatory database stores information on regulations, guidance documents, Acts of Congress, applicable fees, submission information, and/or development timelines. The identification system includes prompt display for presenting user prompts associated with guiding comments. The user prompts comprise multiple choice questions, open-ended questions, or Boolean questions such as true/false questions. The guiding comments are hidden until selected by the user.